✦ LIBER ✦

Epratuzumab + rituximab in refractory or recurrent NHL

Book ID: 120849861
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615510-00015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bendamustine effective in rituximab-refr

Bendamustine effective in rituximab-refractory NHL

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Adding pixantrone to rituximab effective

Adding pixantrone to rituximab effective in refractory NHL

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

R-GIFOX promising for recurrent or refra

R-GIFOX promising for recurrent or refractory aggressive NHL

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Rituximab + chemo effective in refractor

Rituximab + chemo effective in refractory and recurrent lymphomas

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Intensive chemotherapy with hematopoieti

Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL

✍ Sandlund, J.T.; Bowman, L.; Heslop, H.E.; Krance, R.; Mahmoud, H.; Pui, C.-H.; H 📂 Article 📅 2002 🏛 Informa plc 🌐 English ⚖ 116 KB

Phase 2 study of gemcitabine in combinat

Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma

✍ Yasuhiro Oki; Barbara Pro; Luis E. Fayad; Jorge Romaguera; Felipe Samaniego; Fre 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

## Abstract ## BACKGROUND. The management of recurrent or refractory Hodgkin lymphoma (HL) remains challenging. The objective of this phase 2 trial was to investigate the activity of gemcitabine in combination with rituximab in patients with recurring or refractory HL. ## METHODS. Patients were